Home
Tag
Shah Kailash and Associates LLP
1 article
Results
Trident Texofab Q1 PAT at ₹52 Lakh
Trident Texofab reported Q1 FY27 un-audited financial results with ₹52.18 lakh profit and ₹2,614.26 lakh revenue. Statutory Auditor Shah Kailash & Associates LLP resigned effective August 10, 2026, ci